News
Sai Life Sciences consolidated net profit rises 18.09% in the March 2026 quarter
15-May-2026 | 07:37
Sales rise 3.91% to Rs 602.14 crore
Net profit of Sai Life Sciences rose 18.09% to Rs 104.24 crore in the quarter ended March 2026 as against Rs 88.27 crore during the previous quarter ended March 2025. Sales rose 3.91% to Rs 602.14 crore in the quarter ended March 2026 as against Rs 579.51 crore during the previous quarter ended March 2025.
For the full year,net profit rose 105.08% to Rs 348.91 crore in the year ended March 2026 as against Rs 170.13 crore during the previous year ended March 2025. Sales rose 29.38% to Rs 2192.49 crore in the year ended March 2026 as against Rs 1694.57 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 602.14 | 579.51 | 4 | 2192.49 | 1694.57 | 29 |
| OPM % | 29.32 | 27.19 | - | 28.79 | 23.94 | - |
| PBDT | 184.25 | 156.29 | 18 | 641.05 | 366.28 | 75 |
| PBT | 138.94 | 118.80 | 17 | 474.19 | 227.70 | 108 |
| NP | 104.24 | 88.27 | 18 | 348.91 | 170.13 | 105 |
Powered by Capital Market - Live News
